- Home
- AQST vs CAPL Comparison
AQST vs CAPL Comparison
Compare AQST & CAPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AQST | CAPL |
|---|---|---|
| Founded | 2004 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil Refining/Marketing |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 809.3M | 782.2M |
| IPO Year | 2018 | 2012 |
Fundamental Metrics
Financial Performance| Metric | AQST | CAPL |
|---|---|---|
| Price | $5.88 | $21.12 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $8.83 | N/A |
| AVG Volume (30 Days) | ★ 2.3M | 22.3K |
| Earning Date | 11-05-2025 | 11-05-2025 |
| Dividend Yield | N/A | ★ 10.24% |
| EPS Growth | N/A | ★ 129.06 |
| EPS | N/A | ★ 1.19 |
| Revenue | $43,397,000.00 | ★ $3,418,591,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $52.69 | N/A |
| P/E Ratio | ★ N/A | $17.23 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.12 | $19.61 |
| 52 Week High | $7.55 | $25.73 |
Technical Indicators
Market Signals| Indicator | AQST | CAPL |
|---|---|---|
| Relative Strength Index (RSI) | 44.66 | 47.85 |
| Support Level | $5.61 | $20.42 |
| Resistance Level | $6.44 | $20.89 |
| Average True Range (ATR) | 0.31 | 0.36 |
| MACD | -0.05 | 0.01 |
| Stochastic Oscillator | 16.00 | 20.48 |
Price Performance
Historical ComparisonAbout AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
About CAPL CrossAmerica Partners
CrossAmerica Partners LP is engaged in the wholesale distribution of motor fuel and the ownership and leasing of real estate used in the retail distribution of motor fuel. The company operates through two business segments namely Wholesale and Retail. The Wholesale segment is a key revenue driver and includes the wholesale distribution of motor fuel to lessee dealers, independent dealers, commission agents, DMS, Circle K, and through company-operated retail sites. The Retail segment includes the sale of convenience merchandise items, the retail sale of motor fuel at company-operated retail sites, and the retail sale of motor fuel at retail sites operated by commission agents.